In The Fed’s Inflation Fight, Biotech May Be The First Casualty

Serious thought should be given to the effect the anticipated Federal Reserve 0.75% rate hike will have on the biotechnology industry and consequently on the health of the nation.

Read the full post on Forbes - Healthcare